45 Horsehill Road, Suite 106, Cedar Knolls, NJ 07927
(973) 509-0444
Follow us

HomeUniversity of Tampa Clinical Study

If you are a competitive athlete that is interested in gaining muscle mass to up your game, Yolked® with Fortetropin® is an all-natural, advanced nutrition product that can help you achieve your goals.  Go to Yolked.com and learn how NBA basketball star, Aaron Gordon and USWNT star, Carli Lloyd use Yolked to up their game the natural way.

University of Tampa Clinical Study

A randomized, double-blind, placebo-controlled study was performed at the University of Tampa to evaluate the impact of Fortetropin on muscle mass.  Young men, 18-21 years old, were randomly assigned to consume either Fortetropin or placebo for 12 weeks while performing supervised resistance training twice per week.  A dietician worked with each subject weekly and prescribed an individually based diet such that over the course of the study there were no statistical differences in total calories and macronutrients between groups. The key findings were:

Subjects who consumed Fortetropin experienced ~3-fold gains in muscle mass when compared with subjects who received placebo.

No significant change in serum cholesterol levels in any group.

There were no adverse events reported during this clinical study.

Reference:

Sharp MH, Lowery RP, Mobley CB, Fox CD, de Souza EO, Shields KA, Healy JC, Arick NQ, Thompson RM, Roberts MD, Wilson JM. The Effects of Fortetropin Supplementation on Body Composition, Strength, and Power in Humans and Mechanism of Action in a Rodent Model. Journal of the American College of Nutrition. 2016 Nov 16;35(8):679-91.

MYOS CORP is an emerging company focused on improving muscle health through the development of advanced nutrition products.

Contact Us

CORPORATE HEADQUARTERS

Morris Technical Center
45 Horsehill Road, Suite 106
Cedar Knolls, NJ 07927
(973) 509-0444
info@myoscorp.com

SOCIAL & NEWSLETTER

Sign up for
our newsletter

Invalid or empty email
You have successfully subscribed to the newsletter.
Something went wrong. Your subscription failed.

Follow us